PI3K/Akt signaling mediated apoptosis blockage and viral gene expression in oral epithelial cells during herpes simplex virus infection

Virus Research

Volumn 153, Issue 1, 2010, Pages 36-43

  Hsu, Mei Ju ^a   Wu, Ching Yi ^a   Chiang, Hsiao Han ^a   Lai, Yu Lin ^a,b   Hung, Shan Ling ^a,b  

^a NATIONAL YANG MING UNIVERSITY   (Taiwan)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Akt; Apoptosis; Glycogen synthase kinase 3; Herpes simplex virus; Oral epithelial cell; Phosphatidylinositol 3 kinase

Indexed keywords

CASPASE 3; CASPASE 7; GLYCOGEN SYNTHASE KINASE 3; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; THYMIDINE KINASE;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HERPES SIMPLEX; HERPES SIMPLEX VIRUS 1; HUMAN; HUMAN CELL; MOUTH MUCOSA; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; VIRUS EXPRESSION; VIRUS GENE; VIRUS REPLICATION;

APOPTOSIS; CELLS, CULTURED; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, VIRAL; GLYCOGEN SYNTHASE KINASE 3; HERPESVIRUS 1, HUMAN; HUMANS; MOUTH MUCOSA; PHOSPHATIDYLINOSITOL 3-KINASES; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION;

HUMAN HERPESVIRUS 1; SIMPLEXVIRUS;

EID: 77956226596     PISSN: 01681702     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.virusres.2010.07.002     Document Type: Article

References (60)

1. Ahmad R., Ennaciri J., Cordeiro P., El Bassam S., Menezes J. Herpes simplex virus-1 up-regulates IL-15 gene expression in monocytic cells through the activation of protein tyrosine kinase and PKC zeta/lambda signaling pathways. J. Mol. Biol. 2007, 367(1):25-35.
2. Alessi D.R., Andjelkovic M., Caudwell B., Cron P., Morrice N., Cohen P., Hemmings B.A. Mechanism of activation of protein kinase B by insulin and IGF-1. EMBO J. 1996, 15(23):6541-6551.
3. Aubert M., O'Toole J., Blaho J.A. Induction and prevention of apoptosis in human HEp-2 cells by herpes simplex virus type 1. J. Virol. 1999, 73(12):10359-10370.
4. Ben-Hur T., Cialic R., Itzik A., Yirmiya R., Weidenfeld J. Acute effects of purified and UV-inactivated Herpes simplex virus type 1 on the hypothalamo-pituitary-adrenocortical axis. Neuroendocrinology 2001, 74(3):160-166.
5. Benetti L., Roizman B. Herpes simplex virus protein kinase US3 activates and functionally overlaps protein kinase A to block apoptosis. Proc. Natl. Acad. Sci. U.S.A. 2004, 101(25):9411-9416.
6. Benetti L., Roizman B. Protein kinase B/Akt is present in activated form throughout the entire replicative cycle of deltaU(S)3 mutant virus but only at early times after infection with wild-type herpes simplex virus 1. J. Virol. 2006, 80(7):3341-3348.
7. Blaho J.A., Morton E.R., Yedowitz J.C. Current protocols in microbiology. Herpes Simplex Virus: Propagation, Quantification, and Storage 2005, John Wiley & Sons Inc., New York. R. Coico, T. Kowalik, J.M. Quarles, B. Stevenson, R.K. Taylor (Eds.).
8. Chan T.O., Rittenhouse S.E., Tsichlis P.N. AKT/PKB and other D3 phosphoinositide-regulated kinases: kinase activation by phosphoinositide-dependent phosphorylation. Annu. Rev. Biochem. 1999, 68:965-1014.
9. Cohen P., Goedert M. GSK3 inhibitors: development and therapeutic potential. Nat. Rev. Drug Discov. 2004, 3(6):479-487.
10. Cooray S. The pivotal role of phosphatidylinositol 3-kinase-Akt signal transduction in virus survival. J. Gen. Virol. 2004, 85(Pt 5):1065-1076.
11. Dawson C.W., Tramountanis G., Eliopoulos A.G., Young L.S. Epstein-Barr virus latent membrane protein 1 (LMP1) activates the phosphatidylinositol 3-kinase/Akt pathway to promote cell survival and induce actin filament remodeling. J. Biol. Chem. 2003, 278(6):3694-3704.
12. del Peso L., Gonzalez-Garcia M., Page C., Herrera R., Nunez G. Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. Science 1997, 278(5338):687-689.
13. Deregibus M.C., Cantaluppi V., Doublier S., Brizzi M.F., Deambrosis I., Albini A., Camussi G. HIV-1-Tat protein activates phosphatidylinositol 3-kinase/AKT-dependent survival pathways in Kaposi's sarcoma cells. J. Biol. Chem. 2002, 277(28):25195-25202.
14. Fukuda M., Longnecker R. Epstein-Barr virus latent membrane protein 2A mediates transformation through constitutive activation of the Ras/PI3-K/Akt Pathway. J. Virol. 2007, 81(17):9299-9306.
15. Groger S., Michel J., Meyle J. Establishment and characterization of immortalized human gingival keratinocyte cell lines. J. Periodontal Res. 2008, 43(6):604-614.
16. Handler C.G., Eisenberg R.J., Cohen G.H. Oligomeric structure of glycoproteins in herpes simplex virus type 1. J. Virol. 1996, 70(9):6067-6070.
17. Hargett D., McLean T., Bachenheimer S.L. Herpes simplex virus ICP27 activation of stress kinases JNK and p38. J. Virol. 2005, 79(13):8348-8360.
18. Hochman N., Rones Y., Ehrlich J., Levy R., Zakay-Rones Z. Antibodies to herpes simplex virus in human gingival fluid. J. Periodontol. 1981, 52(6):324-327.
19. Honess R.W., Watson D.H. Herpes simplex virus resistance and sensitivity to phosphonoacetic acid. J. Virol. 1977, 21(2):584-600.
20. Huang C.R., Lin S.S., Chou M.Y., Ho C.C., Wang L., Lee Y.L., Chen C.S., Yang C.C. Demonstration of different modes of cell death upon herpes simplex virus 1 infection in different types of oral cells. Acta Virol. 2005, 49(1):7-15.
21. Hung S.-L., Cheng Y.-Y., Wang Y.-H., Chang K.-W., Chen Y.-T. Expression and roles of herpesvirus entry mediators A and C in cells of oral origin. Oral Microbiol. Immunol. 2002, 17(4):215-223.
22. Hung S.-L., Wang Y.-H., Chen H.-W., Lee P.-L., Chen Y.-T. Analysis of herpes simplex virus entering into cells of oral origin. Virus Res. 2002, 86(1-2):59-69.
23. Johnson R.A., Wang X., Ma X.L., Huong S.M., Huang E.S. Human cytomegalovirus up-regulates the phosphatidylinositol 3-kinase (PI3-K) pathway: inhibition of PI3-K activity inhibits viral replication and virus-induced signaling. J. Virol. 2001, 75(13):6022-6032.
24. Jones P.F., Jakubowicz T., Pitossi F.J., Maurer F., Hemmings B.A. Molecular cloning and identification of a serine/threonine protein kinase of the second-messenger subfamily. Proc. Natl. Acad. Sci. U.S.A. 1991, 88(10):4171-4175.
25. Kohn A.D., Kovacina K.S., Roth R.A. Insulin stimulates the kinase activity of RAC-PK, a pleckstrin homology domain containing ser/thr kinase. EMBO J. 1995, 14(17):4288-4295.
26. Kohn A.D., Summers S.A., Birnbaum M.J., Roth R.A. Expression of a constitutively active Akt Ser/Thr kinase in 3T3-L1 adipocytes stimulates glucose uptake and glucose transporter 4 translocation. J. Biol. Chem. 1996, 271(49):31372-31378.
27. Koyama A.H., Fukumori T., Fujita M., Irie H., Adachi A. Physiological significance of apoptosis in animal virus infection. Microbes Infect. 2000, 2(9):1111-1117.
28. Koyama A.H., Miwa Y. Suppression of apoptotic DNA fragmentation in herpes simplex virus type 1-infected cells. J. Virol. 1997, 71(3):2567-2571.
29. Kwun H.J., Yim S.W., Lee D.H., Jang K.L. Activation of the thymidine kinase promoter by herpes simplex virus type 1 immediate-early proteins. Mol. Cells 1999, 9(3):277-280.
30. Lin S.C., Liu C.J., Chiu C.P., Chang S.M., Lu S.Y., Chen Y.J. Establishment of OC3 oral carcinoma cell line and identification of NF-kappa B activation responses to areca nut extract. J. Oral Pathol. Med. 2004, 33(2):79-86.
31. Ling L.-J., Ho C.-C., Wu C.-Y., Chen Y.-T., Hung S.-L. Association between human herpesviruses and the severity of periodontitis. J. Periodontol. 2004, 75(11):1479-1485.
32. Mao J.C., Robishaw E.E. Mode of inhibition of herpes simplex virus DNA polymerase by phosphonoacetate. Biochemistry 1975, 14(25):5475-5479.
33. Mishra R., Barthwal M.K., Sondarva G., Rana B., Wong L., Chatterjee M., Woodgett J.R., Rana A. Glycogen synthase kinase-3beta induces neuronal cell death via direct phosphorylation of mixed lineage kinase 3. J. Biol. Chem. 2007, 282(42):30393-30405.
34. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65(1-2):55-63.
35. Nishiyama S.A., Nakano V., Velasquez-Melendez G., Avila-Campos M.J. Occurrence of herpes simplex virus 1 and three periodontal bacteria in patients with chronic periodontitis and necrotic pulp. Can. J. Microbiol. 2008, 54(4):326-330.
36. Overby L.R., Robishaw E.E., Schleicher J.B., Rueter A., Shipkowitz N.L., Mao J.C. Inhibition of herpes simplex virus replication by phosphonoacetic acid. Antimicrob. Agents Chemother. 1974, 6(3):360-365.
37. Paludan S.R. Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J. Virol. 2001, 75(17):8008-8015.
38. Prejean C., Sarma T., Kurnasov O., Usacheva A., Hemmings B., Cantley L., Fruman D.A., Morrison L.A., Buller R.M., Colamonici O.R. Phosphatidylinositol 3-kinase confers resistance to encephalomyocarditis and herpes simplex virus-induced cell death through the activation of distinct downstream effectors. J. Immunol. 2001, 167(8):4553-4559.
39. Rahaus M., Desloges N., Wolff M.H. Varicella-zoster virus requires a functional PI3K/Akt/GSK-3alpha/beta signaling cascade for efficient replication. Cell Signal. 2007, 19(2):312-320.
40. Roizman B., Knipe D.M. Fields virology. Herpes Simplex Virus and Their Replication, vol. 2 2001, Williams & Wilkins Inc., Lippincott, Philadelphia. 4th ed. D.M. Knipe, P.M. Howley (Eds.).
41. Schabbauer G., Tencati M., Pedersen B., Pawlinski R., Mackman N. PI3K-Akt pathway suppresses coagulation and inflammation in endotoxemic mice. Arterioscler. Thromb. Vasc. Biol. 2004, 24(10):1963-1969.
42. Sciortino M.T., Medici M.A., Marino-Merlo F., Zaccaria D., Giuffre-Cuculletto M., Venuti A., Grelli S., Mastino A. Involvement of HVEM receptor in activation of nuclear factor kappaB by herpes simplex virus 1 glycoprotein D. Cell Microbiol. 2008, 10(11):2297-2311.
43. Sciortino M.T., Medici M.A., Marino-Merlo F., Zaccaria D., Giuffre M., Venuti A., Grelli S., Mastino A. Signaling pathway used by HSV-1 to induce NF-kappaB activation: possible role of herpes virus entry receptor A. Ann. N. Y. Acad. Sci. 2007, 1096:89-96.
44. Shair K.H., Bendt K.M., Edwards R.H., Bedford E.C., Nielsen J.N., Raab-Traub N. EBV latent membrane protein 1 activates Akt, NFkappaB, and Stat3 in B cell lymphomas. PLoS Pathog. 2007, 3(11):e166.
45. Shin Y.K., Liu Q., Tikoo S.K., Babiuk L.A., Zhou Y. Influenza A virus NS1 protein activates the phosphatidylinositol 3-kinase (PI3K)/Akt pathway by direct interaction with the p85 subunit of PI3K. J. Gen. Virol. 2007, 88(Pt 1):13-18.
46. Slots J. Herpesviral-bacterial synergy in the pathogenesis of human periodontitis. Curr. Opin. Infect Dis. 2007, 20(3):278-283.
47. Stow N.D., Stow E.C. Isolation and characterization of a herpes simplex virus type 1 mutant containing a deletion within the gene encoding the immediate-early polypeptide Vmw110. J. Gen. Virol. 1986, 67(Pt 12):2571-2585.
48. Su S.J., Wu H.H., Lin Y.H., Lin H.Y. Comparative studies of types 1 and 2 herpes simplex virus infection of cultured normal keratinocytes. J. Clin. Pathol. 1995, 48(1):75-79.
49. Takeda A., Osaki M., Adachi K., Honjo S., Ito H. Role of the phosphatidylinositol 3'-kinase-Akt signal pathway in the proliferation of human pancreatic ductal carcinoma cell lines. Pancreas 2004, 28(3):353-358.
50. Teng Y.-C., Chen Y.-T., Cheng Y.-Y., Hung S.-L. Requirements for the upregulation of interleukin-6 by herpes simplex virus-infected gingival fibroblasts. Viral Immunol. 2005, 18(1):170-178.
51. Tomita M., Dewan M.Z., Yamamoto N., Kikuchi A., Mori N. Epstein-Barr virus-encoded latent membrane protein 1 activates beta-catenin signaling in B lymphocytes. Cancer Sci. 2009, 100(5):807-812.
52. Tomlinson C.C., Damania B. The K1 protein of Kaposi's sarcoma-associated herpesvirus activates the Akt signaling pathway. J. Virol. 2004, 78(4):1918-1927.
53. Vanhaesebroeck B., Leevers S.J., Ahmadi K., Timms J., Katso R., Driscoll P.C., Woscholski R., Parker P.J., Waterfield M.D. Synthesis and function of 3-phosphorylated inositol lipids. Annu. Rev. Biochem. 2001, 70:535-602.
54. Vlahos C.J., Matter W.F., Hui K.Y., Brown R.F. A specific inhibitor of phosphatidylinositol 3-kinase, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). J. Biol. Chem. 1994, 269(7):5241-5248.
55. Wang L., Damania B. Kaposi's sarcoma-associated herpesvirus confers a survival advantage to endothelial cells. Cancer Res. 2008, 68(12):4640-4648.
56. Whitley R.J., Roizman B. Herpes simplex virus infections. Lancet 2001, 357(9267):1513-1518.
57. Wille J.J., Mansson-Rahemtulla B., Rahemtulla F. Characterization of human gingival keratinocytes cultured in a serum-free medium. Arch. Oral Biol. 1990, 35(12):967-976.
58. Yang C.Y., Meng C.L. Regulation of PG synthase by EGF and PDGF in human oral, breast, stomach, and fibrosarcoma cancer cell lines. J. Dent. Res. 1994, 73(8):1407-1415.
59. Yang L., Dan H.C., Sun M., Liu Q., Sun X.M., Feldman R.I., Hamilton A.D., Polokoff M., Nicosia S.V., Herlyn M., Sebti S.M., Cheng J.Q. Akt/protein kinase B signaling inhibitor-2, a selective small molecule inhibitor of Akt signaling with antitumor activity in cancer cells overexpressing Akt. Cancer Res. 2004, 64(13):4394-4399.
60. Yin W., Signore A.P., Iwai M., Cao G., Gao Y., Johnnides M.J., Hickey R.W., Chen J. Preconditioning suppresses inflammation in neonatal hypoxic ischemia via Akt activation. Stroke 2007, 38(3):1017-1024.